SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is trending as investors react to a new AI infrastructure partnership with Nvidia, which aims to provide secure AI solutions for government and critical infrastructure clients. The community is actively debating the stock's long-term valuation, with many traders pointing to strong free cash flow projections and political visibility as catalysts for a potential reversal following recent volatility.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing strong bullish momentum driven by a recent Wedbush initiation with a significant upside price target and the company's strategic positioning at the intersection of defense and quantum technology following recent White House executive orders. The community is actively discussing a potential short squeeze and the company's unique role as a neutral-atom hardware leader, with many retail investors expressing high conviction in its long-term growth as it secures major government backing.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is generating significant community interest as investors weigh its aggressive expansion into telecommunications and energy markets against a high short interest, which continues to fuel intense debate over a potential short squeeze. Traders are closely monitoring technical support levels and upcoming earnings, with active discussions focusing on the company's patent portfolio and its ability to turn enterprise partnerships into sustained revenue growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on its strong Phase 3 clinical data for its lead prostate cancer candidate and the recent initiation of its global Phase 3 trial for NSCLC. The community is actively discussing the stock's significant pipeline potential, high short interest, and the prospects for potential M&A activity as the company moves toward a BLA submission.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is trending as retail investors rally behind a potential short-squeeze setup, highlighting its small float, high short interest, and low market valuation. Community members are actively debating the mechanics of a squeeze, frequently drawing comparisons to other recent fast-food-sector movers and historical meme-stock surges.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is trending as investors react to the company's newly announced manufacturing expansion with Benchmark Electronics, which aims to scale production of its Rev8 lidar sensors to meet rising demand in robotics and physical AI applications. Community sentiment remains overwhelmingly bullish, with active discussions focusing on the company's BABA-compliant technology, strategic growth in the smart infrastructure sector, and its pivot toward becoming a foundational perception platform for autonomous systems.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark Inc. is currently trending as investors closely watch for news of a potential data center hosting partnership or hyperscaler deal at its Sandersville facility, which continues to drive speculation despite the stock's recent volatility. The community remains deeply divided, with bulls pointing to the company's energy capacity and AI infrastructure transition as long-term catalysts, while bears remain focused on high debt levels, the absence of an official agreement, and the stock's ongoing correlation with Bitcoin price fluctuations.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing intense downward pressure and high volatility as the broader crypto market struggles, with traders heavily debating whether the stock is trapped in a multi-year downtrend or presenting a deep-value opportunity. Community sentiment is deeply polarized, with bears pointing to persistent technical breakdowns and bearish macro catalysts like regulatory delays, while bulls are aggressively targeting potential support levels and holding out hope for a future breakout linked to crypto-market maturation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant volatility driven by heavy short interest and speculative retail trading, while investors simultaneously watch for catalyst potential from upcoming events like their inaugural Investor Day. The community remains deeply divided between those bullish on the long-term data platform moat and those concerned by persistent insider selling and short-term price weakness.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing significant downward pressure following reports that Meta Platforms may commercialize excess AI compute, sparking investor concerns over potential oversupply and increased competition for the neocloud sector. While the community remains divided between those viewing the pullback as a narrative-driven overreaction to a long-term infrastructure trend and those concerned about the erosion of competitive moats for smaller providers, sentiment remains heavily focused on the company's existing multi-year capacity contracts and the broader, supply-constrained nature of AI compute.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 59.7% in Profound Medical (PROF). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of +21.91% and +4.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +50.78% and +18.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical (PROF) Projected to Post Earnings on Thursday

Profound Medical (NASDAQ:PROF) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-profound-medical-corp-stock...

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics Why Medtech Giants Are Quietly Paying Up for AI Diagnostics PR Newswire VANCOUVER, BC, April 29, 2026 ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary There's a...

Profound Medical (TSE:PRN) Trading Down 2.9% - Should You Sell?

Profound Medical (TSE:PRN) Trading Down 2.9% - Here's What Happened...

Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at Conference

Profound Medical (NASDAQ:PROF) highlighted what it described as growing clinical evidence, expanding software capabilities, and improving reimbursement dynamics for its MRI-guided "incision-free" ultrasound platform during a conference presentation led by Arun, a company executive who said he has be...

Profound Medical (NASDAQ:PROF) Shares Down 4.3% - Time to Sell?

Profound Medical (NASDAQ:PROF) Stock Price Down 4.3% - What's Next...

Profound Medical (TSE:PRN) Director Dr. Arun Menawat Purchases 20,000 Shares

Profound Medical Corp. (TSE:PRN - Get Free Report) Director Dr. Arun Menawat purchased 20,000 shares of the stock in a transaction that occurred on Friday, March 20th. The stock was acquired at an average cost of C$6.96 per share, with a total value of C$139,200.00. Following the completion of the...

Insider Buying: Profound Medical (TSE:PRN) Director Acquires 20,000 Shares of Stock

Profound Medical Corp. (TSE:PRN - Get Free Report) Director Dr. Arun Menawat bought 20,000 shares of the stock in a transaction on Friday, March 20th. The shares were acquired at an average cost of...

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Profound Medical Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.75
Prev Close	$6.65
Open	$6.64
Dividend Yield	0.00%
50-Day Moving Average	$6.79
Beta	0.95
Avg. Volume	57,909.06
PE Ratio	-5.41

52-Week High	$8.95
52-Week Low	$3.76
Market Capitalization	$245.28M
EPS (Annual)	-$1.41
Price to Book	4.13
Revenue Per Employee	$99,370.37

Feed

News

Sentiment

Earnings

Fundamentals

Info

PROFProfound Medical Corp

Latest PROF News